These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29322420)

  • 21. Discovery of Zika Virus Dependency and Restriction Factors Using Flow-Based Arrayed CRISPR Screening for Identification of Targets (FACS-IT).
    McDougall WM; Kandpal M; Perreira JM; Brass AL
    Methods Mol Biol; 2020; 2142():215-234. PubMed ID: 32367370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Next-generation libraries for robust RNA interference-based genome-wide screens.
    Kampmann M; Horlbeck MA; Chen Y; Tsai JC; Bassik MC; Gilbert LA; Villalta JE; Kwon SC; Chang H; Kim VN; Weissman JS
    Proc Natl Acad Sci U S A; 2015 Jun; 112(26):E3384-91. PubMed ID: 26080438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Flexible, Pooled CRISPR Library for Drug Development Screens.
    Blanck M; Budnik-Zawilska MB; Lenger SR; McGonigle JE; Martin GRA; le Sage C; Lawo S; Pemberton HN; Tiwana GS; Sorrell DA; Cross BCS
    CRISPR J; 2020 Jun; 3(3):211-222. PubMed ID: 33054419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MISSION LentiPlex pooled shRNA library screening in mammalian cells.
    Coussens MJ; Corman C; Fischer AL; Sago J; Swarthout J
    J Vis Exp; 2011 Dec; (58):. PubMed ID: 22215108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CRISPR/Cas-based customization of pooled CRISPR libraries.
    Kweon J; Kim DE; Jang AH; Kim Y
    PLoS One; 2018; 13(6):e0199473. PubMed ID: 29924860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arrayed CRISPR screen with image-based assay reliably uncovers host genes required for coxsackievirus infection.
    Kim HS; Lee K; Kim SJ; Cho S; Shin HJ; Kim C; Kim JS
    Genome Res; 2018 Jun; 28(6):859-868. PubMed ID: 29712754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimized RNA-targeting CRISPR/Cas13d technology outperforms shRNA in identifying functional circRNAs.
    Zhang Y; Nguyen TM; Zhang XO; Wang L; Phan T; Clohessy JG; Pandolfi PP
    Genome Biol; 2021 Jan; 22(1):41. PubMed ID: 33478577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo shRNA screens in solid tumors.
    Gargiulo G; Serresi M; Cesaroni M; Hulsman D; van Lohuizen M
    Nat Protoc; 2014 Dec; 9(12):2880-902. PubMed ID: 25411954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification.
    Deans RM; Morgens DW; Ökesli A; Pillay S; Horlbeck MA; Kampmann M; Gilbert LA; Li A; Mateo R; Smith M; Glenn JS; Carette JE; Khosla C; Bassik MC
    Nat Chem Biol; 2016 May; 12(5):361-6. PubMed ID: 27018887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An optimized genome-wide, virus-free CRISPR screen for mammalian cells.
    Xiong K; Karottki KJC; Hefzi H; Li S; Grav LM; Li S; Spahn P; Lee JS; Ventina I; Lee GM; Lewis NE; Kildegaard HF; Pedersen LE
    Cell Rep Methods; 2021 Aug; 1(4):. PubMed ID: 34935002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Versatile Viral Vector Strategies for Postscreening Target Validation and RNAi ON-Target Control.
    Christel CJ; Schmied P; Jagusch V; Schrödel S; Thirion C; Schmitt K; Salomon M
    J Biomol Screen; 2015 Sep; 20(8):976-84. PubMed ID: 25873558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR Libraries and Screening.
    Poirier JT
    Prog Mol Biol Transl Sci; 2017; 152():69-82. PubMed ID: 29150005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CRISPR-Cas9 knockout screening for functional genomics.
    Shen Z; Ou G
    Sci China Life Sci; 2014 Jul; 57(7):733-4. PubMed ID: 25005538
    [No Abstract]   [Full Text] [Related]  

  • 34. Rscreenorm: normalization of CRISPR and siRNA screen data for more reproducible hit selection.
    Bachas C; Hodzic J; van der Mijn JC; Stoepker C; Verheul HMW; Wolthuis RMF; Felley-Bosco E; van Wieringen WN; van Beusechem VW; Brakenhoff RH; de Menezes RX
    BMC Bioinformatics; 2018 Aug; 19(1):301. PubMed ID: 30126372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Perspective on the Future of High-Throughput RNAi Screening: Will CRISPR Cut Out the Competition or Can RNAi Help Guide the Way?
    Taylor J; Woodcock S
    J Biomol Screen; 2015 Sep; 20(8):1040-51. PubMed ID: 26048892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pooled shRNA Screen for Reactivation of MeCP2 on the Inactive X Chromosome.
    Leko V; Sripathy S; Adrianse RL; Loe T; Park A; Lao U; Foss EJ; Bartolomei MS; Bedalov A
    J Vis Exp; 2018 Mar; (133):. PubMed ID: 29553562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM.
    Wong AS; Choi GC; Cui CH; Pregernig G; Milani P; Adam M; Perli SD; Kazer SW; Gaillard A; Hermann M; Shalek AK; Fraenkel E; Lu TK
    Proc Natl Acad Sci U S A; 2016 Mar; 113(9):2544-9. PubMed ID: 26864203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimized PCR conditions and increased shRNA fold representation improve reproducibility of pooled shRNA screens.
    Strezoska Ž; Licon A; Haimes J; Spayd KJ; Patel KM; Sullivan K; Jastrzebski K; Simpson KJ; Leake D; van Brabant Smith A; Vermeulen A
    PLoS One; 2012; 7(8):e42341. PubMed ID: 22870320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of Essential Genes Using Sequential CRISPR and siRNA Screens.
    DeHart L; Yockey OP; Bakke J
    Methods Mol Biol; 2022; 2377():89-107. PubMed ID: 34709612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic Target Discovery Using High-Throughput Genetic Screens in Acute Myeloid Leukemia.
    Liu Q; Garcia M; Wang S; Chen CW
    Cells; 2020 Aug; 9(8):. PubMed ID: 32806592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.